Liver Disease: Pathogenesis, Diagnosis, and Treatments
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 21
Special Issue Editor
Special Issue Information
Dear Colleagues,
Liver diseases have led to a higher prevalence of deaths worldwide, including viral hepatitis, metabolic dysfunction-associated steatohepatitis (MASH), alcoholic hepatitis, and liver cancer. Although many prescription drugs have been used for the treatment of the aforementioned liver diseases, therapy resistance and complicated pathogenesis still contribute to therapeutic failure and challenges. In this Special Issue, we are interested in publishing the latest research relating to hepatology, as well as advances in the areas related to pathogenesis, diagnosis, novel targets and biomarkers, molecular mechanisms, therapeutic strategies, and new drug development. Thus, more precise medicine against liver diseases can give patients a better quality of life.
In this Special Issue, original research articles and review articles are welcome. Research areas may include, but are not limited, to the following items:
- Drug development against liver diseases;
- Experimental hepatology;
- Liver disease targets and biomarkers;
- Metabolic syndrome-induced liver diseases;
- Molecular mechanisms of liver diseases;
- Precise therapeutics for liver diseases.
Dr. Hsien-Hui Chung
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- alcoholic hepatitis
- artificial intelligence
- biomarkers
- clinical trials
- gut–liver axis
- liver cancer
- metabolic dysfunction-associated steatohepatitis
- molecular targets
- pharmacotherapeutic mechanisms
- therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
